[Form 4] ROPER TECHNOLOGIES INC Insider Trading Activity
Roper Technologies (ROP) Form 4 — Irene M. Esteves
Director Irene M. Esteves was granted 59 restricted stock units (RSUs) on 09/15/2025 under the company's Director Compensation Plan. Each RSU represents a contingent right to one share and the award carries a reported price of $0. The RSUs vest on the six-month anniversary of the grant date. Following this grant, the reporting person beneficially owns 3,775 shares of Roper common stock. The reporting person has elected to defer receipt of the underlying shares under the company’s Non-Qualified Retirement Plan. The form is signed by an attorney-in-fact on behalf of the reporting person.
- Director compensation was documented transparently with a timely Form 4 filing detailing the RSU grant
- Grant vests on a defined schedule (six-month anniversary), providing clarity on timing of potential share delivery
- Reporting person elected deferral under the company’s Non-Qualified Retirement Plan, indicating use of established plan provisions
- None.
Insights
TL;DR: Routine director equity grant; limited market impact.
This Form 4 discloses a standard director compensation event: a grant of 59 restricted stock units to a company director, vesting in six months and deferred under a retirement plan. The grant size relative to total outstanding shares is not provided, so the transaction appears administrative and non-dilutive in isolation. There is no cash purchase price and no derivative activity reported. From an earnings or liquidity perspective, the filing does not introduce material changes to the company’s financial position based on the information supplied.
TL;DR: Compensation disclosure aligns with common governance practices for directors.
The filing documents a director award under the Director Compensation Plan with a standard deferral election into a Non-Qualified Retirement Plan. Vesting after six months is a clear, time-based condition. The report is signed by an attorney-in-fact, indicating procedural compliance. No unusual terms, immediate dispositions, or related-party transactions are disclosed that would raise governance concerns based on the text provided.